S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

LON:VECVectura Group Share Price, Forecast & News

GBX 98.70
+0.90 (+0.92 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
93.78
Now: GBX 98.70
100.42
50-Day Range
86.90
MA: GBX 96.13
105.20
52-Week Range
59.10
Now: GBX 98.70
107
Volume533,429 shs
Average Volume4.61 million shs
Market Capitalization£594.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta and Anoro Ellipta for the treatment of COPD. Its generic partnering products include flutiform, VR315, VR506, VR730, VR632, VR2081, VR410, and Ellipta for the treatment of asthma; and Phase I clinical stage product is the VR475 (US) for the treatment of severe adult asthma. The company's Phase II clinical stage products comprise VR465 for treating respiratory syncytial virus infection; VR647 for the treatment of paediatric asthma; and VR736 for the treatment severe influenza. Its Phase III clinical stage products include QVM149 for the treatment of asthma; and VR475 (EU) for the treatment of severe adult asthma. The company also provides dry powder inhalers; pressurized meter dose inhalers; and smart nebulizers. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.
Read More
Vectura Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1249-667700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£178.30 million
Cash FlowGBX 12.02 per share
Book ValueGBX 69.20 per share

Profitability

Miscellaneous

Employees478
Market Cap£594.20 million
Next Earnings DateN/A
OptionableOptionable

Receive VEC News and Ratings via Email

Sign-up to receive the latest news and ratings for VEC and its competitors with MarketBeat's FREE daily newsletter.

Vectura Group (LON:VEC) Frequently Asked Questions

How has Vectura Group's stock been impacted by COVID-19 (Coronavirus)?

Vectura Group's stock was trading at GBX 81 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VEC shares have increased by 21.9% and is now trading at GBX 98.70. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Vectura Group?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Vectura Group.

How often does Vectura Group pay dividends? What is the dividend yield for Vectura Group?

Vectura Group announced a dividend on Tuesday, September 10th. Stockholders of record on Monday, October 14th will be given a dividend of GBX 6 per share on Friday, October 25th. The ex-dividend date is Monday, October 14th. The official announcement can be viewed at this link. View Vectura Group's dividend history.

What price target have analysts set for VEC?

4 brokers have issued 1-year price objectives for Vectura Group's shares. Their forecasts range from GBX 114 to GBX 115. On average, they anticipate Vectura Group's stock price to reach GBX 114.50 in the next year. This suggests a possible upside of 16.0% from the stock's current price. View analysts' price targets for Vectura Group.

Has Vectura Group been receiving favorable news coverage?

Media headlines about VEC stock have trended somewhat negative on Tuesday, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vectura Group earned a news impact score of -1.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Vectura Group.

Who are some of Vectura Group's key competitors?

What other stocks do shareholders of Vectura Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SkyePharma (SKP), BTG (BTG), iRobot (IRBT), SINR PHAR/PAR VTG FPD 0.01 (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:
  • Mr. James Ward-Lilley, CEO & Exec. Director (Age 54)
  • Mr. Paul Fry, CFO & Exec. Director
  • Mr. Anthony Fitzpatrick, Exec. VP of Operations
  • Elizabeth Knowles, Director of Investor Relations & Analysis
  • Mr. John Murphy, Gen. Counsel & Company Sec. (Age 66)

What is Vectura Group's stock symbol?

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

How do I buy shares of Vectura Group?

Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Vectura Group's stock price today?

One share of VEC stock can currently be purchased for approximately GBX 98.70.

How big of a company is Vectura Group?

Vectura Group has a market capitalization of £594.20 million and generates £178.30 million in revenue each year. Vectura Group employs 478 workers across the globe.

What is Vectura Group's official website?

The official website for Vectura Group is www.vectura.com.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company can be reached via phone at +44-1249-667700.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.